- Home
- DXYZ vs BBNX Comparison
DXYZ vs BBNX Comparison
Compare DXYZ & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DXYZ | BBNX |
|---|---|---|
| Founded | N/A | 2015 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 974.9M | 997.9M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | DXYZ | BBNX |
|---|---|---|
| Price | $25.95 | $15.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $25.10 |
| AVG Volume (30 Days) | 774.1K | ★ 1.1M |
| Earning Date | N/A | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 78.95 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $100,251,000.00 |
| Revenue This Year | N/A | $25.28 |
| Revenue Next Year | N/A | $47.19 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 53.94 |
| 52 Week Low | $19.71 | $8.80 |
| 52 Week High | $72.87 | $32.71 |
Technical Indicators
Market Signals| Indicator | DXYZ | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 37.14 | 38.87 |
| Support Level | $26.24 | $15.92 |
| Resistance Level | $29.81 | $18.20 |
| Average True Range (ATR) | 1.44 | 1.39 |
| MACD | -0.23 | -0.16 |
| Stochastic Oscillator | 23.83 | 0.57 |
Price Performance
Historical ComparisonAbout DXYZ Destiny Tech100 Inc.
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It is designed to be an investment portfolio of the Top 100 High-Growth Tech Companies.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.